In various cancer cell lines, the expression of B3GNT5 was evaluated, revealing that the HNSC, ESCA, small cell lung cancer (SCLC), and PAAD cell lines exhibited the highest levels of B3GNT5 expression (Fig 1D). This evidence concerns the gene B3GNT5 and cancer.